Indoco Remedies commissioned a new state-of-the-art API manufacturing facility at Patalganga on November 27,2018.

This new cGMP compliant facility will enhance the existing manufacturing capacity from 150 tons to 600 tons p.a. Major highlights of the facility include, solvent recovery system, automation, energy conservation and Zero Liquid Discharge Effluent Treatment facility. Emphasis on process safety and lant safety has been given by incorporating sophisticated safety devices.

Shares of INDOCO REMEDIES LTD. was last trading in BSE at Rs.219.25 as compared to the previous close of Rs. 210.1. The total number of shares traded during the day was 46918 in over 1640 trades.

The stock hit an intraday high of Rs. 222.2 and intraday low of 203. The net turnover during the day was Rs. 9967948.

Source: Equity Bulls